CYTOGENETIC AND GENOME RESEARCH is a pivotal journal dedicated to the exploration of cytogenetics, genomics, and their applications within clinical genetics and molecular biology. Published by KARGER in Switzerland, this journal aims to foster comprehensive discussions and disseminate impactful research from diverse fields related to genetics. It operates under an open access model, ensuring that researchers, professionals, and students can easily access and contribute to the latest findings. With coverage spanning from 1962 to 2024, CYTOGENETIC AND GENOME RESEARCH continues to serve as a vital resource, despite its current categorization in the Q4 quartile across Genetics and Molecular Biology. It provides an avenue for advancing the understanding of genomic mechanisms and their implications for human health. The journal encourages submissions that delve into cutting-edge methodologies, data interpretation, and theoretical frameworks, thereby playing a crucial role in the advancement of genetic research and its clinical applications.

Frontiers in Genome Editing, published by FRONTIERS MEDIA SA, stands at the forefront of genomic research, specializing in the rapidly evolving realm of gene editing technologies. With an enthusiastic commitment to open access since 2020, this journal facilitates unrestricted distribution of cutting-edge research, making significant advancements in biotechnology and genetics accessible to a global audience. Located in Lausanne, Switzerland, Frontiers in Genome Editing publishes high-quality, peer-reviewed articles that contribute to the understanding and application of genome editing tools, such as CRISPR and TALEN, in various biological fields. Notably, as of 2023, the journal holds a prestigious Q1 ranking in Biotechnology and a Q2 ranking in Genetics, underscoring its importance and influence within these disciplines. With robust Scopus rankings, including a notable percentile placement, Frontiers in Genome Editing is an invaluable resource for researchers, professionals, and students dedicated to the promising future of genomic innovation.

GENOMICS PROTEOMICS & BIOINFORMATICS, published by Elsevier, stands at the forefront of cutting-edge research in the fields of genomics, proteomics, and bioinformatics. This esteemed journal, with an impact factor reflecting its significant influence, has embraced an Open Access model since its inception in 2003, ensuring that knowledge is freely accessible to a global community of researchers, professionals, and students. Based in China, it has been recognized for its exemplary contributions, achieving Q1 quartile rankings in major categories such as Biochemistry, Computational Mathematics, Genetics, and Molecular Biology as of 2023. Moreover, its commendable Scopus rankings position it among the top journals in its fields, with outstanding percentile performances that highlight its scholarly impact. As it continues to converge from 2003 to 2024, the journal aims to foster innovation and collaboration, making it an essential platform for disseminating vital insights and advancements in molecular life sciences.

Plant Gene is an esteemed academic journal dedicated to the comprehensive study of plant genetics, genomics, and biotechnology. Published by Elsevier, this journal operates from its base in the Netherlands and has made significant strides since its inception in 2015, with a converged year span extending until 2024. As an integral resource in the field, Plant Gene is categorized in the Q2 quartile for Plant Science and Q3 for Biochemistry, Biotechnology, and Genetics as per the 2023 evaluations, reflecting its growing influence and quality of research. With an impactful presence in Scopus rankings—positioned at #145 in Plant Science—this journal serves as a platform for presenting innovative findings and advancing knowledge in plant science. Researchers, professionals, and students will find access to cutting-edge research articles that not only drive the scientific community forward but also offer invaluable insights into the genetic mechanisms underpinning plant development and resilience. While the journal currently operates under a subscription-based model, it aims to broaden accessibility and foster a diverse range of scholarly discussions in the ever-evolving field of plant genetics.

Genes & Genomics is a prominent academic journal dedicated to the fields of biochemistry, genetics, and molecular biology, published by Springer from South Korea. With an evolving focus on innovative genetic research and its implications, this journal serves as a crucial platform for disseminating knowledge within the scientific community. The journal has been indexed in Scopus and boasts a Q3 quartile ranking in 2023 for its contributions to these disciplines, highlighting its relevance and growing impact. In addition to traditional subscription options, Genes & Genomics supports Open Access, offering broader accessibility for researchers and enthusiasts eager to explore the latest advancements in genetic studies. Since its inception in 2008, the journal has committed to publishing high-quality research that drives forward our understanding of genetics and its applications, making it an essential resource for researchers, professionals, and students alike who are passionate about the complexities and breakthroughs in genomic sciences.

Genome Medicine is a prestigious, peer-reviewed journal published by BMC, focusing on the rapidly evolving fields of genetics, molecular biology, and molecular medicine. Established in 2009 and boasting an open-access format, it has become a leading platform for disseminating high-quality research findings that advance our understanding of genetic diseases and therapeutic innovations. With an impressive Q1 ranking across multiple relevant categories—in particular, genetics (clinical), molecular biology, and molecular medicine—this journal is recognized for its substantial impact in the academic community, as evidenced by its exceptional placement in Scopus rankings. By providing unrestricted access to groundbreaking studies, Genome Medicine fosters collaboration and knowledge sharing among researchers, clinicians, and educators, thus playing a vital role in the transition from fundamental genetic research to clinical applications. Researchers are encouraged to contribute their findings and insights, further solidifying the journal’s position as a pivotal resource for those dedicated to advancing genomic medicine.

The CRISPR Journal, published by MARY ANN LIEBERT, INC, is a pioneering platform dedicated to advancing the field of genetics and biotechnology through innovative research focused on CRISPR technology and its diverse applications. With an impressive Q1 ranking in both Biotechnology and Genetics for 2023, this journal is positioned among the leading publications in its field, showcasing groundbreaking studies from 2019 to 2024. While currently utilizing a subscription model, the journal's commitment to open science is reflected in its efforts to make high-quality research accessible to researchers, professionals, and students. The CRISPR Journal facilitates the dissemination of knowledge related to genomic editing technologies, fostering collaboration and advancing the understanding of gene manipulation, therapeutic techniques, and agricultural innovations. As a valuable resource for cutting-edge developments in the biochemistry and genetics landscape, this journal is essential for those seeking to stay at the forefront of CRISPR research and applications.

Mitochondrial DNA Part B-Resources, published by TAYLOR & FRANCIS LTD, is a prominent academic journal focusing on the vast and evolving field of genetics and molecular biology. As an open access resource, it is dedicated to providing valuable insights and comprehensive data on mitochondrial DNA, an area crucial for understanding cellular functions, genetic inheritance, and various diseases. Although relatively new, having commenced in 2016, the journal has gained recognition with its current Scopus rankings placing it in the lower quartiles for both Genetics and Molecular Biology. It serves as an essential platform for researchers, professionals, and students at the intersection of genetics and biotechnology, fostering collaboration and innovation. With a commitment to quality research and accessibility, Mitochondrial DNA Part B-Resources is poised to contribute significantly to the scientific community until at least 2024 and beyond.

The EUROPEAN JOURNAL OF HUMAN GENETICS, published by SpringerNature, stands as a preeminent platform in the field of genetics and clinical genetics. Established in 1993, this prestigious journal, with an ISSN of 1018-4813 and an E-ISSN of 1476-5438, has consistently maintained its position in the Q1 quartile for both Genetics and Clinical Genetics categories as of 2023, reflecting its significant contributions to the field. Its impact is further underscored by its impressive Scopus rankings, placing it in the 92nd percentile among clinical genetics journals. The journal aims to disseminate cutting-edge research, case studies, and reviews that advance our understanding of human genetics, promoting collaboration and innovation among researchers, professionals, and students alike. While it does not currently offer open access, the journal provides substantial value through its rigorous peer review process and commitment to quality. As it continues to shape the future of genetic research through 2024 and beyond, the EUROPEAN JOURNAL OF HUMAN GENETICS remains an essential resource for those dedicated to exploring the complexities of human heredity.

MAMMALIAN GENOME is a leading journal in the field of genetics, aimed at advancing our understanding of the genetic makeup and evolutionary relationships of mammals. Published by Springer, this journal has been a cornerstone resource since its inception in 1991, converging extensive research up to 2024. With a commendable Q2 classification in the 2023 Genetics category and a Scopus Rank of #208 out of 347, it serves as a vital platform for sharing cutting-edge findings, methodologies, and reviews pertaining to mammalian genomes. Although not an open-access journal, MAMMALIAN GENOME ensures that its content is accessible through institutional subscriptions, catering to a global audience of researchers, professionals, and students. Its commitment to excellence in genetic research positions it as an essential publication for anyone striving to contribute to this dynamic field.